4164. Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.
作者: Freddie C Hamdy.;Jenny L Donovan.;J Athene Lane.;Chris Metcalfe.;Michael Davis.;Emma L Turner.;Richard M Martin.;Grace J Young.;Eleanor I Walsh.;Richard J Bryant.;Prasad Bollina.;Andrew Doble.;Alan Doherty.;David Gillatt.;Vincent Gnanapragasam.;Owen Hughes.;Roger Kockelbergh.;Howard Kynaston.;Alan Paul.;Edgar Paez.;Philip Powell.;Derek J Rosario.;Edward Rowe.;Malcolm Mason.;James W F Catto.;Tim J Peters.;Jon Oxley.;Naomi J Williams.;John Staffurth.;David E Neal.; .
来源: N Engl J Med. 2023年388卷17期1547-1558页
Between 1999 and 2009 in the United Kingdom, 82,429 men between 50 and 69 years of age received a prostate-specific antigen (PSA) test. Localized prostate cancer was diagnosed in 2664 men. Of these men, 1643 were enrolled in a trial to evaluate the effectiveness of treatments, with 545 randomly assigned to receive active monitoring, 553 to undergo prostatectomy, and 545 to undergo radiotherapy.
|